Thomas Wilson Eastling insider trades
Open-market stock purchases and sales by Thomas Wilson Eastling, Chief Financial Officer at Gyre Therapeutics, Inc, from SEC Form 4 filings since Oct 31, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 4, 2026 | GYRE Gyre Therapeutics, Inc | Bought (not open market) | — |
| May 4, 2026 | GYRE Gyre Therapeutics, Inc | Bought (not open market) | — |
| May 4, 2026 | GYRE Gyre Therapeutics, Inc | Bought (not open market) | — |
| May 4, 2026 | GYRE Gyre Therapeutics, Inc | Bought (not open market) | — |
| May 4, 2026 | GYRE Gyre Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- GYRE Gyre Therapeutics, Inc: other filings, last May 4, 2026
Get free alerts when Thomas Wilson Eastling files a new trade →